Cargando…
The Antidepressant-Like Effects of a Clinically Relevant Dose of Ketamine Are Accompanied by Biphasic Alterations in Working Memory in the Wistar Kyoto Rat Model of Depression
Major depressive disorder (MDD) is the leading cause of disability worldwide. The majority of antidepressant drugs require several weeks or months of treatment to demonstrate efficacy and a subset of patients are resistant to such interventions. Ketamine demonstrates rapid and long-lasting antidepre...
Autores principales: | McDonnell, Conor W., Dunphy-Doherty, Fionn, Rouine, Jennifer, Bianchi, Massimiliano, Upton, Neil, Sokolowska, Ewa, Prenderville, Jack A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863985/ https://www.ncbi.nlm.nih.gov/pubmed/33551869 http://dx.doi.org/10.3389/fpsyt.2020.599588 |
Ejemplares similares
-
PS118. Single administration of ketamine and Pregnenolone-Methyl-Ether (3ß-Methoxy-Pregnenolone) has antidepressant efficacy in a preclinical model of treatment resistant depression: identification of a plasma biomarker of pharmacological efficacy
por: Jack, Prenderville, et al.
Publicado: (2016) -
Ketamine promptly normalizes excess norepinephrine and enhances dopamine neuronal activity in Wistar Kyoto rats
por: Daniels, Stephen, et al.
Publicado: (2023) -
AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar–Kyoto rats
por: Papp, Mariusz, et al.
Publicado: (2020) -
Learned helplessness and social avoidance in the Wistar-Kyoto rat
por: Nam, Hyungwoo, et al.
Publicado: (2014) -
Differences in free amino acid concentrations in milk between Wistar and
Wistar Kyoto rats
por: HAMADA, Mizuki, et al.
Publicado: (2019)